Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??
Vascular Pharmacology · 2024
DOI: 10.1016/j.vph.2023.107253 ↗Kurz gefasst
Editorial in der Zeitschrift Vascular Pharmacology, 2024. Verfasst von William E Boden. Beteiligte Einrichtung: VA New England Healthcare System, Boston University School of Medicine, and Harvard Medical School, Boston, MA, USA. Electronic address: william.bode…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
The optimal management of chronic coronary syndrome (CCS) patients has been a source of debate for several decades. Herein, we describe the evidence base comprising several landmark clinical trials including the most recent ISCHEMIA Trial, which, in aggregate, does not demonstrate a conclusive, incremental benefit of revascularization combined with optimal medical therapy (OMT) versus OMT alone in reducing prognostically-important clinical outcomes during long-term follow-up. For CCS patients with symptoms or quality of life not deemed refractory or unacceptable on medical therapy, a conservative approach to the judicious and selective use of revascularization plus OMT remains a justifiable evidence-based management strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VA New England Healthcare System, Boston University School of Medicine, and Harvard Medical School, Boston, MA, USA. Electronic address: william.boden@va.gov.
Zitieren
APA
Boden, W. E. (2024). Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2023.107253
Vancouver
Boden WE. Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??. Vascular Pharmacology. 2024. doi:10.1016/j.vph.2023.107253
BibTeX
@article{Boden2024,
author = {Boden, William E},
title = {Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??},
journal = {Vascular Pharmacology},
year = {2024},
doi = {10.1016/j.vph.2023.107253}
}
EUVIMED